Connect your AI

Zymeworks ZYME Value of shares repurchased

Value of shares repurchased at other companies

AshlandASH

$25M-73.9%

AdientADNT

$25M0.0%

CarGurus, Inc.CARG

$176.61M-5.0%

AvePoint, Inc.AVPT

$61.12M+413%

Proto LabsPRLB

$6.17M-57.3%

Century CommunitiesCCS

$40.01M-28.0%

Other financials

Income statement

Revenue$2.4M-91.1%

Operating income-$47.1M-84.0%

Net income-$44.2M-95.1%

EPS (diluted)-$0.59-96.7%

Balance sheet

Cash & equivalents$244.3M+221%

Total debt$17.0M-7.7%

Total equity$163.6M-49.7%

Total assets$478.2M+12.4%

Cash flow

Operating cash flow-$45.7M-1,242%

CapEx$216.0K+1,250%

Free cash flow-$45.9M-1,242%

Valuation

Market cap$1.79B+125%

Profitability

Operating margin-140.4%+7.3pp

Net margin-126.3%+5.0pp

FCF margin-94.8%+15.5pp

Returns & leverage

Return on equity-42%+29.2pp

Debt / equity0.1×0.0×

Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:StockRepurchasedAndRetiredDuringPeriodValue.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's value of shares repurchased.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Zymeworks's value of shares repurchased?: Zymeworks (ZYME) reported value of shares repurchased of $76.15M in Q1 2026.